Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Borgo in connection with the establishment of its MTN and covered bond programme and its inaugural issuance of MTNs
Mandate

Vinge advises Borgo in connection with the establishment of its MTN and covered bond programme and its inaugural issuance of MTNs

February 03, 2022 Banking and Finance

Vinge has advised Borgo AB (publ) (“Borgo”) in connection with the establishment of its SEK 50 billion MTN and covered bond programme (the “Programme”) and its inaugural issuance of SEK 1,75 billion MTNs (the “MTNs”).

The covered bonds issued under the Programme will be secured by underlying Swedish mortgage loans in accordance with the Swedish Covered Bonds Act. The MTNs carry an interest rate of STIBOR 3M + 0,90% and are intended to be listed on the corporate bond list of Nasdaq Stockholm. The Programme also caters for future issuances of green medium term notes, at the discretion of Borgo.

Borgo is a new independent mortgage lending company co-owned by ICA Banken, Ikano Bank, Söderberg & Partners and Ålandsbanken. Additional investors and Sparbanken Syd have committed to invest in Borgo. Borgo focuses on financing and offering mortgages to Swedish consumers.

Vinge’s team mainly consisted of Mikael Ståhl, Lionardo Ojeda, Axel Jansson and Felix Möller.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025